A phase I/II study of Lonsurf combined with Oxaliplatin in metastatic colorectal cancer patients refractory to standard chemotherapy.
Latest Information Update: 13 Mar 2019
At a glance
- Drugs Oxaliplatin (Primary) ; Tipiracil/trifluridine (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms LUPIN study
Most Recent Events
- 06 Mar 2019 Results published in the Investigational New Drugs
- 29 Nov 2018 Status changed from active, no longer recruiting to completed.
- 01 Nov 2018 Status changed from recruiting to active, no longer recruiting.